Jade Biosciences stock forecast
Want to see JBIO full AI Analyst Report?
Jade Biosciences (JBIO) Stock Forecast & Price Target
JBIO Analyst Ratings
JBIO Stock 12 Month Forecast
Average Price Target
$50.86▲(207.48% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Julian Harrison | BTIG | $77 | buy | 365.54%Upside | Reiterated | 10/26/26 | ||
| Vamil Divan | Guggenheim | $47 | buy | 184.16%Upside | Reiterated | 10/15/26 | ||
| Arthur He CFA | H.C. Wainwright | $55 | buy | 232.53%Upside | Reiterated | 10/01/26 | ||
| David Nierengarten | Wedbush | $47 | buy | 184.16%Upside | Reiterated | 10/01/26 | ||
| Rami Katkhuda | LifeSci Capital | $42 | buy | 153.93%Upside | Reiterated | 09/30/26 | ||
| Matt Phipps | William Blair | ― | buy | ― | Reiterated | 09/30/26 | ||
| Kaveri Pohlman | Clear Street | $25→$48 | buy | 190.21%Upside | Assigned | 09/04/26 | ||
| Alex Thompson CFA | Stifel Nicolaus | $40 | buy | 141.84%Upside | Reiterated | 08/13/26 | ||
| Akash Tewari | Jefferies | $40→$48 | buy | 190.21%Upside | Reiterated | 08/11/26 | ||
| Tyler Van Buren | TD Cowen | ― | buy | ― | Reiterated | 08/10/26 | ||
| Michael Yee | UBS | $45 | buy | 172.07%Upside | Initiated | 06/15/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Julian HarrisonBTIG | BuyReiterated$77 | 10/26/26 | 365.54%Upside | ||
| Vamil DivanGuggenheim | BuyReiterated$47 | 10/15/26 | 184.16%Upside | ||
| Arthur He CFAH.C. Wainwright | BuyReiterated$55 | 10/01/26 | 232.53%Upside | ||
| David NierengartenWedbush | BuyReiterated$47 | 10/01/26 | 184.16%Upside | ||
| Rami KatkhudaLifeSci Capital | BuyReiterated$42 | 09/30/26 | 153.93%Upside | ||
| Matt PhippsWilliam Blair | BuyReiterated | 09/30/26 | ― | ||
| Kaveri PohlmanClear Street | BuyAssigned$25→$48 | 09/04/26 | 190.21%Upside | ||
| Alex Thompson CFAStifel Nicolaus | BuyReiterated$40 | 08/13/26 | 141.84%Upside | ||
| Akash TewariJefferies | BuyReiterated$40→$48 | 08/11/26 | 190.21%Upside | ||
| Tyler Van BurenTD Cowen | BuyReiterated | 08/10/26 | ― | ||
| Michael YeeUBS | BuyInitiated$45 | 06/15/26 | 172.07%Upside |
Best Analysts Covering Jade Biosciences
Copying Vamil Divan's trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of -1.14% per trade.
Copying Tyler Van Buren's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +51.42% per trade.
Copying Tyler Van Buren's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +27.09% per trade.
JBIO Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 11 | 15 | 10 | 15 | 8 |
| Buy | 8 | 4 | 4 | 3 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 19 | 19 | 14 | 18 | 9 |
In the current month, JBIO has received 9 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. JBIO average Analyst price target in the past 3 months is 50.86.
JBIO Financial Forecast
JBIO Earnings Forecast
Next quarter’s earnings estimate for JBIO is -$0.73 with a range of -$0.86 to -$0.57. The previous quarter’s EPS was -$0.76. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
JBIO Sales Forecast
Next quarter’s sales forecast for JBIO is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
